Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento

Detalhes bibliográficos
Ano de defesa: 2006
Autor(a) principal: Marques-santos, Celi lattes
Orientador(a): Oliveira, Manuel Hermínio de Aguiar lattes
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Sergipe
Programa de Pós-Graduação: Pós-Graduação em Ciências da Saúde
Departamento: Não Informado pela instituição
País: BR
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: https://ri.ufs.br/handle/riufs/3902
Resumo: The present research has the objective to determinate the seric PCR concentrations in the monogenic isolated deficiency of the growth hormone (DIGH), test the hypothesis that DIGH is associated to the exacerbation of the inflammatory profile, identify the PCR elevation predictors, and evaluate the existence of an association between PCR and premature atherosclerosis. The growth hormone (GH) has as its main function the post-natal longitudinal growth; it interferes in the bone apposition, muscle mass growth, opposes to the action of insulin in the carbohydrates and lipids metabolism, and, in the cardiovascular system, helps the vascular and myocardial remodeling. IGF-I, GH primary mediator, plays a fundamental role in the growth regulation, cellular apoptosis and differentiation. The GH/IGF-I axis acts in the resistance to insulin and phenotypical expression of cardiovascular risk factors, associated to metabolic syndrome. IGF-I avoids the endothelial dysfunction, causes the increase of sensitivity to insulin, and avoids post-prandial dyslipidemia, besides presenting anti-inflammatory and anti-apoptotic activities. The decrease of IGF-I is associated to premature atherosclerosis and high cardiovascular risk. IGF-I role is controversial and its increase is related to the premature atherosclerosis in carotids. The deficiency of GH is associated to the increase of cardiovascular and brain vascular mortality. The inflammation plays an essential role in the atherosclerosis physiopathology from its initial phase up to atherotrombotic events in acute coronary syndromes. C - reactive protein, acute phase reagent of the inflammation, is produced by the liver, due mainly to the interleukin-6 stimulus. As a predictor and a mediator of atherosclerosis, among all circulating inflammatory markers, it is the most stable, the most studied and the one which presented the most constant relationship to future cardiovascular risk in various clinical situations, including asymptomatic individuals. In Itabaininha, Sergipe state we described a population with DIGH, with extremely low levels of IGF-I, high LDL-c and systolic arterial pressure and central obesity, a cluster of risk factors, highly susceptible to atherosclerosis ideal to this research. From this population, eighteen individuals were studied, eight male and ten female, with an average age of 45, compared to a control group composed of twenty individuals of the same region. After the clinical and metabolic characteristics were analyzed, the most relevant results were: PCR showed a meaningful difference between the groups (4,9 mg/l (4,7) vs 1,4 mg/l (2,2)); and IGF-I extremely low (1,0 ng/ml (1,0) vs 164,0 ng/ml (135,0)). The group predicts that PCR is independent from the other metabolic variables (R² = 0, 42), and that IGF-I is the main responsible for the increase of PCR in the DIGH. No association between PCR and the intimatemedia thickness of the carotids could be observed. Conclusion: it was demonstrated that the DIGH present high levels of PCR when compared to the control group; the variable group predicts this variation and IGF-I is the main responsible for the PCR variability. High PCR is not associated to premature atherosclerosis in this high risk differentiated group.
id UFS-2_5fdbd81175c55edc44f059806aa83e2a
oai_identifier_str oai:ufs.br:riufs/3902
network_acronym_str UFS-2
network_name_str Repositório Institucional da UFS
repository_id_str
spelling Marques-santos, Celihttp://lattes.cnpq.br/9237658656139251Oliveira, Manuel Hermínio de Aguiarhttp://lattes.cnpq.br/10445985800020772017-09-26T12:18:51Z2017-09-26T12:18:51Z2006-09-12MARQUES-SANTOS, Celi. Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento. 2006. 104 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2006.https://ri.ufs.br/handle/riufs/3902The present research has the objective to determinate the seric PCR concentrations in the monogenic isolated deficiency of the growth hormone (DIGH), test the hypothesis that DIGH is associated to the exacerbation of the inflammatory profile, identify the PCR elevation predictors, and evaluate the existence of an association between PCR and premature atherosclerosis. The growth hormone (GH) has as its main function the post-natal longitudinal growth; it interferes in the bone apposition, muscle mass growth, opposes to the action of insulin in the carbohydrates and lipids metabolism, and, in the cardiovascular system, helps the vascular and myocardial remodeling. IGF-I, GH primary mediator, plays a fundamental role in the growth regulation, cellular apoptosis and differentiation. The GH/IGF-I axis acts in the resistance to insulin and phenotypical expression of cardiovascular risk factors, associated to metabolic syndrome. IGF-I avoids the endothelial dysfunction, causes the increase of sensitivity to insulin, and avoids post-prandial dyslipidemia, besides presenting anti-inflammatory and anti-apoptotic activities. The decrease of IGF-I is associated to premature atherosclerosis and high cardiovascular risk. IGF-I role is controversial and its increase is related to the premature atherosclerosis in carotids. The deficiency of GH is associated to the increase of cardiovascular and brain vascular mortality. The inflammation plays an essential role in the atherosclerosis physiopathology from its initial phase up to atherotrombotic events in acute coronary syndromes. C - reactive protein, acute phase reagent of the inflammation, is produced by the liver, due mainly to the interleukin-6 stimulus. As a predictor and a mediator of atherosclerosis, among all circulating inflammatory markers, it is the most stable, the most studied and the one which presented the most constant relationship to future cardiovascular risk in various clinical situations, including asymptomatic individuals. In Itabaininha, Sergipe state we described a population with DIGH, with extremely low levels of IGF-I, high LDL-c and systolic arterial pressure and central obesity, a cluster of risk factors, highly susceptible to atherosclerosis ideal to this research. From this population, eighteen individuals were studied, eight male and ten female, with an average age of 45, compared to a control group composed of twenty individuals of the same region. After the clinical and metabolic characteristics were analyzed, the most relevant results were: PCR showed a meaningful difference between the groups (4,9 mg/l (4,7) vs 1,4 mg/l (2,2)); and IGF-I extremely low (1,0 ng/ml (1,0) vs 164,0 ng/ml (135,0)). The group predicts that PCR is independent from the other metabolic variables (R² = 0, 42), and that IGF-I is the main responsible for the increase of PCR in the DIGH. No association between PCR and the intimatemedia thickness of the carotids could be observed. Conclusion: it was demonstrated that the DIGH present high levels of PCR when compared to the control group; the variable group predicts this variation and IGF-I is the main responsible for the PCR variability. High PCR is not associated to premature atherosclerosis in this high risk differentiated group.Esta pesquisa demonstra de forma original o grau de inflamação relacionado à deficiência isolada monogênica do hormônio de crescimento (DIGH) através da determinação das concentrações plasmáticas da proteína C reativa (PCR), testa a hipótese de a DIGH estar associada à exacerbação do perfil inflamatório, identifica os preditores da elevação da PCR e avalia a associação de inflamação com aterosclerose precoce. O hormônio de crescimento (GH) tem como função principal, o crescimento longitudinal pós-natal; interfere na aposição óssea, crescimento da massa muscular, opõe-se à ação da insulina no metabolismo dos carboidratos e lipídios e, no aparelho cardiovascular, atua no remodelamento miocárdico e vascular. A sua deficiência está associada ao aumento de mortalidade por doenças cardio e cérebro vasculares. O IGF-I, mediador primário do GH, desempenha papel fundamental na regulação do crescimento, diferenciação e apoptose celular. O eixo GH/IGF-I interfere quanto à resistência à insulina e na expressão fenotípica dos fatores de risco cardiovasculares, associados à síndrome metabólica. O IGF-I evita a disfunção endotelial, promove o aumento da sensibilidade à insulina previne a dislipidemia pós-prandial, além de possuir atividade anti-inflamatória e antiapoptótica. A diminuição do IGF-I está associada à aterosclerose prematura e elevado risco cardiovascular. O papel do IGF-I é controverso e o seu aumento está associado ao aparecimento precoce de aterosclerose em carótidas. A inflamação exerce papel fundamental na fisiopatologia da aterosclerose. A PCR, reagente de fase aguda da inflamação é produzida pelo fígado, em decorrência principalmente do estímulo da interleucina-6. Entre os marcadores inflamatórios circulantes, é a mais estável, a mais estudada e a que apresentou relação mais constante com o risco cardiovascular futuro em diversas situações clínicas, incluindo indivíduos assintomáticos; A PCR é considerada preditora e mediadora da aterosclerose. Em Itabaianinha, Sergipe, foi descrita uma população com DIGH, níveis extremamente baixos de IGF-I, LDL e pressão arterial sistólica elevados, obesidade central, portanto, uma população com múltiplos fatores de risco, altamente susceptível à aterosclerose. Este estudo inseriu 18 indivíduos DIGH, oito do sexo masculino e dez do feminino, idade média de 45 anos, e 20 controles (CO) da mesma região. Analisadas as características clínicas e metabólicas, o grupo DIGH apresentou PCR de (4,9 mg/l (4,7) vs controles (CO) 1,4 mg/l (2,2) com importante diferença significativa (p<0,0001); o IGF-I dos DIGH foi extremamente baixo, 1,0 ng/ml (1,0) vs 164,0 ng/ml (135,0) dos CO, p< 0,0001. O grupo é que prediz ser a PCR independente das outras variáveis metabólicas (R2 = 0,42) e o IGF- I é o principal responsável pelo aumento da PCR nos DIGH. Não houve nenhuma relação de associação entre a PCR e a espessura média-íntima das carótidas do DIGH. Conclusão: ficou demonstrado que os DIGH apresentam níveis muito elevados de PCR que denota um perfil inflamatório exacerbado; o grupo é que prediz esta variação e, o IGF-I é o principal responsável pelo variabilidade da PCR. A PCR elevada na DIGH não está associada à aterosclerose precoce.application/pdfporUniversidade Federal de SergipePós-Graduação em Ciências da SaúdeUFSBREndocrinologiaCardiologiaProteína C ReativaInflamaçãoAteroscleroseDeficiência do Hormônio de CrescimentoIGF-ISíndrome metabólicaNanismo hipofisárioC-reactive proteinInflammationAtherosclerosisGrowth hormone deficiencyIGF-IMetabolic SyndromeCNPQ::CIENCIAS DA SAUDEProteína C reativa na deficiência isolada monogênica do hormônio de crescimentoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSTEXTCELI_MARQUES_SANTOS.pdf.txtCELI_MARQUES_SANTOS.pdf.txtExtracted texttext/plain130420https://ri.ufs.br/jspui/bitstream/riufs/3902/2/CELI_MARQUES_SANTOS.pdf.txt1d79797a4853a5b128762b370541b59eMD52THUMBNAILCELI_MARQUES_SANTOS.pdf.jpgCELI_MARQUES_SANTOS.pdf.jpgGenerated Thumbnailimage/jpeg1376https://ri.ufs.br/jspui/bitstream/riufs/3902/3/CELI_MARQUES_SANTOS.pdf.jpgfa27853b8937522bac8e66847a66d1d5MD53ORIGINALCELI_MARQUES_SANTOS.pdfapplication/pdf2620073https://ri.ufs.br/jspui/bitstream/riufs/3902/1/CELI_MARQUES_SANTOS.pdf65505b4bda7414131e904d841a3054b3MD51riufs/39022017-11-28 17:03:14.366oai:ufs.br:riufs/3902Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2017-11-28T20:03:14Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false
dc.title.por.fl_str_mv Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
title Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
spellingShingle Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
Marques-santos, Celi
Endocrinologia
Cardiologia
Proteína C Reativa
Inflamação
Aterosclerose
Deficiência do Hormônio de Crescimento
IGF-I
Síndrome metabólica
Nanismo hipofisário
C-reactive protein
Inflammation
Atherosclerosis
Growth hormone deficiency
IGF-I
Metabolic Syndrome
CNPQ::CIENCIAS DA SAUDE
title_short Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
title_full Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
title_fullStr Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
title_full_unstemmed Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
title_sort Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento
author Marques-santos, Celi
author_facet Marques-santos, Celi
author_role author
dc.contributor.author.fl_str_mv Marques-santos, Celi
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/9237658656139251
dc.contributor.advisor1.fl_str_mv Oliveira, Manuel Hermínio de Aguiar
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/1044598580002077
contributor_str_mv Oliveira, Manuel Hermínio de Aguiar
dc.subject.por.fl_str_mv Endocrinologia
Cardiologia
Proteína C Reativa
Inflamação
Aterosclerose
Deficiência do Hormônio de Crescimento
IGF-I
Síndrome metabólica
Nanismo hipofisário
topic Endocrinologia
Cardiologia
Proteína C Reativa
Inflamação
Aterosclerose
Deficiência do Hormônio de Crescimento
IGF-I
Síndrome metabólica
Nanismo hipofisário
C-reactive protein
Inflammation
Atherosclerosis
Growth hormone deficiency
IGF-I
Metabolic Syndrome
CNPQ::CIENCIAS DA SAUDE
dc.subject.eng.fl_str_mv C-reactive protein
Inflammation
Atherosclerosis
Growth hormone deficiency
IGF-I
Metabolic Syndrome
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE
description The present research has the objective to determinate the seric PCR concentrations in the monogenic isolated deficiency of the growth hormone (DIGH), test the hypothesis that DIGH is associated to the exacerbation of the inflammatory profile, identify the PCR elevation predictors, and evaluate the existence of an association between PCR and premature atherosclerosis. The growth hormone (GH) has as its main function the post-natal longitudinal growth; it interferes in the bone apposition, muscle mass growth, opposes to the action of insulin in the carbohydrates and lipids metabolism, and, in the cardiovascular system, helps the vascular and myocardial remodeling. IGF-I, GH primary mediator, plays a fundamental role in the growth regulation, cellular apoptosis and differentiation. The GH/IGF-I axis acts in the resistance to insulin and phenotypical expression of cardiovascular risk factors, associated to metabolic syndrome. IGF-I avoids the endothelial dysfunction, causes the increase of sensitivity to insulin, and avoids post-prandial dyslipidemia, besides presenting anti-inflammatory and anti-apoptotic activities. The decrease of IGF-I is associated to premature atherosclerosis and high cardiovascular risk. IGF-I role is controversial and its increase is related to the premature atherosclerosis in carotids. The deficiency of GH is associated to the increase of cardiovascular and brain vascular mortality. The inflammation plays an essential role in the atherosclerosis physiopathology from its initial phase up to atherotrombotic events in acute coronary syndromes. C - reactive protein, acute phase reagent of the inflammation, is produced by the liver, due mainly to the interleukin-6 stimulus. As a predictor and a mediator of atherosclerosis, among all circulating inflammatory markers, it is the most stable, the most studied and the one which presented the most constant relationship to future cardiovascular risk in various clinical situations, including asymptomatic individuals. In Itabaininha, Sergipe state we described a population with DIGH, with extremely low levels of IGF-I, high LDL-c and systolic arterial pressure and central obesity, a cluster of risk factors, highly susceptible to atherosclerosis ideal to this research. From this population, eighteen individuals were studied, eight male and ten female, with an average age of 45, compared to a control group composed of twenty individuals of the same region. After the clinical and metabolic characteristics were analyzed, the most relevant results were: PCR showed a meaningful difference between the groups (4,9 mg/l (4,7) vs 1,4 mg/l (2,2)); and IGF-I extremely low (1,0 ng/ml (1,0) vs 164,0 ng/ml (135,0)). The group predicts that PCR is independent from the other metabolic variables (R² = 0, 42), and that IGF-I is the main responsible for the increase of PCR in the DIGH. No association between PCR and the intimatemedia thickness of the carotids could be observed. Conclusion: it was demonstrated that the DIGH present high levels of PCR when compared to the control group; the variable group predicts this variation and IGF-I is the main responsible for the PCR variability. High PCR is not associated to premature atherosclerosis in this high risk differentiated group.
publishDate 2006
dc.date.issued.fl_str_mv 2006-09-12
dc.date.accessioned.fl_str_mv 2017-09-26T12:18:51Z
dc.date.available.fl_str_mv 2017-09-26T12:18:51Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv MARQUES-SANTOS, Celi. Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento. 2006. 104 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2006.
dc.identifier.uri.fl_str_mv https://ri.ufs.br/handle/riufs/3902
identifier_str_mv MARQUES-SANTOS, Celi. Proteína C reativa na deficiência isolada monogênica do hormônio de crescimento. 2006. 104 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2006.
url https://ri.ufs.br/handle/riufs/3902
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Sergipe
dc.publisher.program.fl_str_mv Pós-Graduação em Ciências da Saúde
dc.publisher.initials.fl_str_mv UFS
dc.publisher.country.fl_str_mv BR
publisher.none.fl_str_mv Universidade Federal de Sergipe
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFS
instname:Universidade Federal de Sergipe (UFS)
instacron:UFS
instname_str Universidade Federal de Sergipe (UFS)
instacron_str UFS
institution UFS
reponame_str Repositório Institucional da UFS
collection Repositório Institucional da UFS
bitstream.url.fl_str_mv https://ri.ufs.br/jspui/bitstream/riufs/3902/2/CELI_MARQUES_SANTOS.pdf.txt
https://ri.ufs.br/jspui/bitstream/riufs/3902/3/CELI_MARQUES_SANTOS.pdf.jpg
https://ri.ufs.br/jspui/bitstream/riufs/3902/1/CELI_MARQUES_SANTOS.pdf
bitstream.checksum.fl_str_mv 1d79797a4853a5b128762b370541b59e
fa27853b8937522bac8e66847a66d1d5
65505b4bda7414131e904d841a3054b3
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)
repository.mail.fl_str_mv repositorio@academico.ufs.br
_version_ 1793351101431414784